乳腺癌
小RNA
外周血单个核细胞
癌症
肿瘤科
阶段(地层学)
接收机工作特性
内科学
医学
基因表达谱
生物
癌症研究
基因表达
基因
遗传学
体外
古生物学
作者
Sanjay Mishra,Amit Kumar Srivastava,Shankar Suman,Vijay Kumar,Yogeshwer Shukla
出处
期刊:Cancer Letters
[Elsevier BV]
日期:2015-08-11
卷期号:369 (1): 67-75
被引量:88
标识
DOI:10.1016/j.canlet.2015.07.045
摘要
The miRNAs have well studied roles in cancer. Here, we identified altered miRNA expression by global miRNA profiling in peripheral blood mononuclear cells (PBMCs) of breast cancer (n = 15) and healthy subjects (n = 15), and further validated the selected miRNAs in PBMCs (n = 45), blood plasma (n = 45) and breast tissue samples (n = 09). The expression of altered miRNAs was also evaluated in PBMCs among early stage (n = 32), advanced stage (n = 13), triple positive (n = 5) and triple negative (n = 5) breast cancer patients. Results showed differential pattern of expressions of these miRNAs in multiple cohorts, however in early stage breast cancer, miR-106a-5p and miR-454-3p were upregulated (p < 0.05), miR-195-5p and miR-495 were downregulated (p < 0.05) in PBMCs. In addition, these miRNAs were also significantly associated with cancer and ErbB signaling pathways. Multiple regression analysis and receiver-operative curve (ROC) analysis of miR-195-5p and miR-495 with area under curve (AUC) of 0.901 showed best discriminating combination for early stage breast cancer detection. In summary, the present study delineated the importance of miR-195-5p and miR-495 miRNAs as prospective circulating surrogate molecular signatures for early detection of breast cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI